GE HealthCare Technologies Inc. with ticker code (GEHC) have now 11 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $97.00 and $66.00 calculating the average target price we see $83.14. Now with the previous closing price of $71.14 and the analysts are correct then we can expect a percentage increase in value of 16.9%. The 50 day MA is $68.03 and the 200 day MA is $74.54. The total market capitalization for the company now stands at 31.86B. The current share price for the company is: $69.98 USD
The potential market cap would be $37,231,746,516 based on the market consensus.
The company has a dividend yield of 0.77%. Other points of data to note are a P/E ratio of 20.77, revenue per share of $42.36 and a 6.17% return on assets.
GE HealthCare Technologies Inc. is a global medical technology, pharmaceutical diagnostics, and digital solutions company. The Company develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. The Company’s segments include Imaging, Ultrasound, Patient Care Solutions and Pharmaceutical Diagnostics. The Imaging segment includes scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment includes screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment includes medical devices, services, consumable products, services, and digital solutions. The Pharmaceutical Diagnostics segment is a supplier of diagnostic agents to the global radiology and nuclear medicine industry.
